...
首页> 外文期刊>Pharmacogenomics >Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment
【24h】

Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment

机译:儿茶酚-O-甲基转移酶(COMT)基因与精神分裂症及抗精神病药物反应的相关性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: We investigated the catechol-O-methyltrasferase (COMT) gene, which is a strong functional and positional candidate gene for schizophrenia and therapeutic response to antipsychotic medication. Materials & methods: Single-locus as well as detailed haplotype-based association analysis of the COMT gene with schizophrenia and antipsychotic treatment response was carried out using seven COMT polymorphisms in 398 schizophrenia patients and 241 healthy individuals from a homogeneous south Indian population. Further responsiveness to risperidone treatment was assessed in 117 schizophrenia patients using Clinical Global Impressions (CGI). A total of 69 patients with a CGI score of 2 or less met the criteria of good responders and 48 were patients who continued to have a score of 3 and above and were classified as poor responders to risperidone treatment. Results: The association of SNP rs4680 with schizophrenia did not remain significant after adjusting for multiple testing. Haplotype analysis showed highly significant association of seven COMT marker haplotypes with schizophrenia (CLUMP T4 p-value = 0.0001). Our results also demonstrated initial significant allelic associations of two SNPs with drug response (rs4633: χ2 = 4.36, p-value = 0.036, OR: 1.80, 95% CI: 1.03–3.15; and rs4680: χ2 = 4.02, p-value = 0.044, OR: 1.76, 95% CI: 1.01–3.06) before multiple correction. We employed two-marker sliding window analysis for haplotype association and observed a significant association of markers located between intron 1 and intron 2 (rs737865, rs6269: CLUMP T4 p-value = 0.021); and in exon 4 (rs4818, rs4680: CLUMP T4 p-value = 0.028) with drug response. Conclusion: The present study thus indicates that the interacting effects within the COMT gene polymorphisms may influence the disease status and response to risperidone in schizophrenia patients. However, the study needs to be replicated in a larger sample set for confirmation, followed by functional studies.
机译:目的:我们研究了儿茶酚-O-甲基转移酶(COMT)基因,该基因是精神分裂症和抗精神病药物治疗反应的强大功能和位置候选基因。材料与方法:利用7种COMT多态性,对398名精神分裂症患者和241名来自印度南部同族的健康个体进行了单基因座以及基于单倍型的COMT基因与精神分裂症和抗精神病治疗反应的详细关联分析。使用临床总体印象(CGI)在117位精神分裂症患者中评估了对利培酮治疗的进一步反应。共有69例患者的CGI得分为2或更低,达到了良好反应者的标准,其中48例患者的得分仍在3分以上,并且被归为利培酮治疗的不良反应者。结果:经过多次测试调整后,SNP rs4680与精神分裂症之间的关联并不显着。单倍型分析显示七种COMT标记单倍型与精神分裂症高度相关(CLUMP T4 p值= 0.0001)。我们的结果还证明了两个SNP与药物反应的初始显着等位基因相关性(rs4633:χ 2 = 4.36,p值= 0.036,或:1.80,95%CI:1.03-3.15;以及rs4680: χ 2 = 4.02,p值= 0.044,或:1.76,95%CI:1.01-3.06)。我们采用了两标记滑动窗口分析进行单倍型关联,并观察到位于内含子1和内含子2之间的标记之间存在显着关联(rs737865,rs6269:CLUMP T4 p值= 0.021);并在第4外显子(rs4818,rs4680:CLUMP T4 p值= 0.028)中出现药物反应。结论:本研究因此表明COMT基因多态性内的相互作用可能影响精神分裂症患者的疾病状态和对利培酮的反应。但是,需要将研究复制到更大的样本集中进行确认,然后进行功能研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号